- Avoiding doctors like the plague
- Podcast 14: Alcohol-related harm in general practice
- Managing diabetes is not all about expensive medication
- My perfect medical statistics day
- GP Sceptics podcast 13: Nurses’ conflicts-of-interest
- A textbook case walked into the room
- Vitamins: mostly harmless, mostly profitable
- Post-truth therapy: alternative medicine with alternative facts
- Drug seeker basted me like a turkey
- 48-second GP consultations
- ‘Junior’ doctors: what’s in a label?
- GP Sceptics podcast 12: Doctors’ resilience
- GP Sceptics podcast 11: Medically Unexplained Symptoms
- How to measure med student empathy
- The Fed endures, and so must we
- Tamiflu: an expensive lesson in panic stockpiling
- GP Sceptics podcast 10: GPs at the Deep End
- Pain clinics: how did such a fresh idea turn sour?
- Not just a GP – I’m your specialist in uncertainty
- GP Sceptics podcast 9: The Environment
- Let’s celebrate the bolt-cutter surgeon
- Greater transparency on specialist fees: a no-brainer
- Four Corners Big Vitamins exposé: cuts both ways
- Five reasons why I’d still encourage my child to do medicine
- GP Sceptics podcast 8: Marketing
- Google Health Cards: the first test drive
- GP sceptics podcast 7: EBM Hijacked!
- Does the weather affect our joints?
- GP Sceptics podcast 6: Obesity – Christmas edition
- Anne Deveson, who destigmatised schizophrenia
- Why ‘medicine for the rich’ is sometimes inevitable
- GP Sceptics podcast 5: Lyme disease…don’t get sold a lemon
- GP Sceptics podcast 4: Addiction
- Homeopathy: US mandates ‘No evidence’ labels
- With Obamacare gone, how will Trumpcare affect US health?
- Mothers, don’t plan on early delivery unless it’s medically necessary.
- GP Sceptics pod3: Pain
- GP Sceptics podcast 2: Diabetes
- Starts at 60 interview
- GP Sceptics podcast 1: Big Soda
Tag Archives: diabetes
Justin Coleman reflects on what matters for diabetes management in his final DMJ editorial. Continue reading
Justin and Liz ask the hard questions and give the easy answers about diagnosis of diabetes. Continue reading
I spend a lot of time highlighting the commercial forces that promote expensive medical interventions. So yesterday, when I read a lead author describe his new guidelines as “the most radical change in the treatment of type 2 diabetes for almost … Continue reading